Instructions for Sorbex capsules 0.25 g blister No. 20
Composition
active ingredient: activated charcoal;
1 capsule contains 0.25 g of activated charcoal;
excipients: gelatin, black iron oxide (E 172), diamond black (E 151).
Dosage form
Capsules.
Main physicochemical properties: black capsule body, black cap with or without white marking “SORBEX”. Capsule contents – black loose powder.
Pharmacotherapeutic group
Enterosorbents. Code ATX A07B A01.
Pharmacological properties
Pharmacodynamics
The enterosorbent SORBEX® has a detoxifying effect.
The active ingredient of the drug SORBEX® is activated charcoal of plant origin with a developed active surface, capable of adsorbing gases and liquid toxic compounds that are formed and accumulate in excess during acute and chronic diseases or enter the body from the outside.
Pharmacokinetics
Activated charcoal is a non-toxic, inert substance. While in the body, it does not undergo chemical changes or metabolic transformations, is not absorbed from the intestinal lumen, does not pass beyond the gastrointestinal tract, is not detected in any concentrations in biological fluids, and is eliminated from the body through the intestines.
Indication
SORBEX® is used:
– in chronic poisoning with household and industrial toxins (alkaloids, heavy metal salts, other substances), food, drugs, alcohol and food overloads in order to reduce absorption, prevent further absorption and accelerate the removal of toxic substances from the body;
– when living in adverse environmental conditions or exposed to harmful production factors, changing the usual diet during vacation, business trip, or travel;
as adjunctive therapy:
– for disorders and infectious diseases of the gastrointestinal tract (dyspepsia, flatulence, intestinal infections, acute and chronic viral hepatitis);
– in diseases accompanied by endogenous intoxication syndrome: acute and chronic liver and kidney damage, allergic, autoimmune and oncological diseases, as well as with elevated cholesterol levels.
Contraindication
Individual hypersensitivity to the sorbent. Ulcerative and erosive lesions of the gastrointestinal tract in the acute stage, gastrointestinal bleeding, intestinal obstruction.
Interaction with other medicinal products and other types of interactions
Having adsorbing properties, activated charcoal can reduce the effectiveness of drugs taken simultaneously with it. Therefore, with concomitant pharmacotherapy, SORBEX® is taken 1-1.5 hours before or after taking other drugs.
Provided that the method of administration is followed, the drug can be used in complex therapy with other medications.
Application features
Women taking contraceptives are recommended to use other contraceptives during treatment with SORBEX®.
Taking the drug and food at the same time reduces the adsorption activity of the drug, so SORBEX® is taken 1-1.5 hours before or after eating.
Long-term use (more than 15 days) may be accompanied by malabsorption and cause a deficiency of vitamins, hormones, fats, and proteins in the body, which requires appropriate medical or nutritional correction.
After taking the drug SORBEX®, the stool turns black.
In the presence of hypovitaminosis, which may be accompanied by prolonged use of activated charcoal, multivitamins should be prescribed.
The capsules of the drug SORBEX® contain diamond black dye (E 151), which may cause allergic reactions.
Ability to influence reaction speed when driving vehicles or other mechanisms
SORBEX® is not contraindicated when driving or operating other machinery.
Use during pregnancy or breastfeeding
There is no data on the negative effects of the drug SORBEX® during pregnancy or breastfeeding.
Method of administration and doses
For flatulence and dyspepsia, adults should take 1-3 capsules 3-4 times a day.
For poisoning and intoxication, adults should take 2-6 capsules 3 times a day.
Children aged 7 and over should take 1-3 capsules 3-4 times a day.
The drug should be used 1.5 - 2 hours before or after meals or taking medications, with water.
The course of treatment for acute conditions is up to 3-5 days, for chronic diseases caused by endogenous intoxications - up to 10-15 days.
Children
It is not advisable for children under 7 years of age to use the drug in this dosage form.
Overdose
Significantly exceeding the maximum single doses may lead to side effects: nausea, vomiting, constipation.
Adverse reactions
Nausea, vomiting and hypersensitivity reactions are possible. Prolonged use may be accompanied by intestinal dysfunction (diarrhea, constipation), which are easily eliminated by stopping the drug and prescribing symptomatic therapy. Prolonged use (more than 15 days) may be accompanied by malabsorption and cause a deficiency of vitamins, hormones, fats, proteins in the body, which requires appropriate medical or nutritional correction.
If you experience any side effects not listed in the instructions for use, immediately inform your doctor!
Expiration date
3 years.
Storage conditions
Store in original packaging at a temperature not exceeding 25 ° C. Store separately from substances and materials that emit gases and vapors.
Keep out of reach of children.
Packaging
Capsules of 0.25 g, 10 capsules in a blister, 2 blisters in a pack.
Vacation category
Without a prescription.
Producer
LLC "VALARTIN PHARMA".
Location of the manufacturer and its business address
Ukraine, 08135, Kyiv region, Kyiv-Svyatoshynskyi district, Chayky village, Hrushevskoho st., building 60.
